Phase I/IIa Dose-escalation Clinical Study of VAC-3S

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
InnaVirVax
ClinicalTrials.gov Identifier:
NCT01549119
First received: March 2, 2012
Last updated: December 18, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2014
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)